346 related articles for article (PubMed ID: 30917957)
41. Platelet binding of IgG from patients with heparin-induced thrombocytopenia.
Horne MK; Alkins BR
J Lab Clin Med; 1996 May; 127(5):435-42. PubMed ID: 8621980
[TBL] [Abstract][Full Text] [Related]
42. Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia.
Pouplard C; Iochmann S; Renard B; Herault O; Colombat P; Amiral J; Gruel Y
Blood; 2001 May; 97(10):3300-2. PubMed ID: 11342462
[TBL] [Abstract][Full Text] [Related]
43. Further characterization of antibody and antigen in heparin-induced thrombocytopenia.
Newman PM; Chong BH
Br J Haematol; 1999 Nov; 107(2):303-9. PubMed ID: 10583216
[TBL] [Abstract][Full Text] [Related]
44. Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and FcγRIIA.
Palankar R; Kohler TP; Krauel K; Wesche J; Hammerschmidt S; Greinacher A
J Thromb Haemost; 2018 Jun; 16(6):1187-1197. PubMed ID: 29350833
[TBL] [Abstract][Full Text] [Related]
45. Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies.
Krauel K; Hackbarth C; Fürll B; Greinacher A
Blood; 2012 Feb; 119(5):1248-55. PubMed ID: 22049520
[TBL] [Abstract][Full Text] [Related]
46. [Anti-heparin/platelet factor 4 antibodies and heparin-induced thrombocytopenia--review].
Lei Q; Chen L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):457-60. PubMed ID: 18426686
[TBL] [Abstract][Full Text] [Related]
47. Heparin-induced thrombocytopenia: the role of platelets genetic polymorphisms.
Pamela S; Anna Maria L; Elena D; Giovanni M; Emanuele A; Silvia V; Carmen B; Andreas G; Fabrizio F
Platelets; 2013; 24(5):362-8. PubMed ID: 22793995
[TBL] [Abstract][Full Text] [Related]
48. PF4-HIT antibody (KKO) complexes activate broad innate immune and inflammatory responses.
Haile LA; Rao R; Polumuri SK; Arepally GM; Keire DA; Verthelyi D; Sommers CD
Thromb Res; 2017 Nov; 159():39-47. PubMed ID: 28968537
[TBL] [Abstract][Full Text] [Related]
49. COVID-19 patients often show high-titer non-platelet-activating anti-PF4/heparin IgG antibodies.
Brodard J; Kremer Hovinga JA; Fontana P; Studt JD; Gruel Y; Greinacher A
J Thromb Haemost; 2021 May; 19(5):1294-1298. PubMed ID: 33550713
[TBL] [Abstract][Full Text] [Related]
50. Platelet-activating anti-PF4 disorders: An overview.
Warkentin TE
Semin Hematol; 2022 Apr; 59(2):59-71. PubMed ID: 35512902
[TBL] [Abstract][Full Text] [Related]
51. Distinct Binding Characteristics of Pathogenic Anti-Platelet Factor-4/Polyanion Antibodies to Antigens Coated on Different Substrates: A Perspective on Clinical Application.
Nguyen TH; Greinacher A
ACS Nano; 2018 Dec; 12(12):12030-12041. PubMed ID: 30540167
[TBL] [Abstract][Full Text] [Related]
52. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications.
Rauova L; Zhai L; Kowalska MA; Arepally GM; Cines DB; Poncz M
Blood; 2006 Mar; 107(6):2346-53. PubMed ID: 16304054
[TBL] [Abstract][Full Text] [Related]
53. Polymorphism of the Fcγ Receptor II as a Possible Predisposing Factor for Heparin-Induced Thrombocytopenia.
Slavik L; Svobodova G; Ulehlova J; Krcova V; Hlusi A; Prochazkova J; Hutyra M
Clin Lab; 2015; 61(8):1027-32. PubMed ID: 26427148
[TBL] [Abstract][Full Text] [Related]
54. Importance of the FcgammaRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosis.
Bachelot-Loza C; Saffroy R; Lasne D; Chatellier G; Aiach M; Rendu F
Thromb Haemost; 1998 Mar; 79(3):523-8. PubMed ID: 9531034
[TBL] [Abstract][Full Text] [Related]
55. Heparin-induced thrombocytopenia: IgG binding to PF4-heparin complexes in the fluid phase and cross-reactivity with low molecular weight heparin and heparinoid.
Newman PM; Swanson RL; Chong BH
Thromb Haemost; 1998 Aug; 80(2):292-7. PubMed ID: 9716155
[TBL] [Abstract][Full Text] [Related]
56. Testing for heparin-induced thrombocytopenia antibodies.
Warkentin TE; Sheppard JA
Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164
[TBL] [Abstract][Full Text] [Related]
57. Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia.
Perdomo J; Leung HHL; Ahmadi Z; Yan F; Chong JJH; Passam FH; Chong BH
Nat Commun; 2019 Mar; 10(1):1322. PubMed ID: 30899022
[TBL] [Abstract][Full Text] [Related]
58. Studies of the immune response in heparin-induced thrombocytopenia.
Warkentin TE; Sheppard JA; Moore JC; Cook RJ; Kelton JG
Blood; 2009 May; 113(20):4963-9. PubMed ID: 19144981
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of automated immunoassays in the diagnosis of heparin induced thrombocytopenia.
Althaus K; Hron G; Strobel U; Abbate R; Rogolino A; Davidson S; Greinacher A; Bakchoul T
Thromb Res; 2013 Mar; 131(3):e85-90. PubMed ID: 23351665
[TBL] [Abstract][Full Text] [Related]
60. Variable serotonin release assay pattern and specificity of PF4-specific antibodies in HIT, and clinical relevance.
Rollin J; Charuel N; Gruel Y; Billy S; Guéry EA; May MA; Pouplard C; Vayne C
J Thromb Haemost; 2022 Nov; 20(11):2646-2655. PubMed ID: 35971886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
